September 19, 2018
A new scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk. The study was published today in the Sept. 12 edition of the scientific journal, Nature. Additional data from the research has been made […]
